AlexandersNYSE: ALX

ALX Oncology valuation has dropped below $500 million, presenting new studies at venues like ASCO, reaching a point of inflection. Evorpacept is the main focus, showing promising activity signals in gastric cancer and urothelial carcinoma, with upcoming data updates and trials. Financially, ALXO has a reasonable cash pool to fund operations for the near term, with a runway of 5-6 quarters.

Vancouver, British Columbia--(Newsfile Corp. - June 13, 2024) - ALX Resources Corp. (TSXV: AL) (FSE: 6LLN) (OTC: ALXEF) ("ALX" or the "Company") is pleased to announce the results of the 2024 winter drilling program and upcoming summer 2024 exploration plans at its Gibbons Creek Uranium Project ("Gibbons Creek", or the "Project") located in the northern Athabasca Basin near the community of Stony Rapids, Saskatchewan. Gibbons Creek is the subject of an option earn-in transaction with Trinex Lithium Ltd.

What could be better than a large dividend?

Alexander's (ALX) reported quarterly funds from operations (FFO) of $4.98 per share, falling short of the Zacks Consensus Estimate of $6.41 per share. This is higher than the FFO of $3.63 per share reported in the same quarter last year.

Alexander's, Inc. (NYSE: ALX) stated today that it will submit its Form 10-Q for the quarter ending March 31, 2024 to the U.S. Securities and Exchange Commission and release its first quarter earnings on Monday, May 6, 2024, before the New York Stock Exchange begins trading.

ALX, ATLC and DCOM have been added to the Zacks Rank #5 (Strong Sell) List on April 2, 2023.

Alexander's (ALX) came out with quarterly funds from operations (FFO) of $4.99 per share, missing the Zacks Consensus Estimate of $5.95 per share. This compares to FFO of $4.03 per share a year ago.

Alexander's, Inc. is a REIT that owns and manages 5 retail properties in New York City. The REIT's operating performance is concerning, with low occupancy rates and minimal revenue growth. There are also risks associated with portfolio concentration, significant tenant dependency, and upcoming mortgage maturities.

ALX, PHI and PSTL made it to the Zacks Rank #1 (Strong Buy) income stocks list on December 21, 2023.